Beneficial effects of topical testosterone replacement in patients with end-stage liver disease

Digestive Diseases and Sciences

Volumn 49, Issue 7-8, 2004, Pages 1186-1189

  Neff, Guy W ^a   O'Brien, Christopher B ^a   Montalbano, Marzia ^a   Meyer, Douglas ^a   DeManno, Antoinette ^a   Muslu, Halim ^a   Safdar, Kamran ^a   Kahn, Stephanie ^a   Nishida, Seigo ^a   Schiff, Eugene R ^a  

^a M   (United States)

Author keywords

end stage liver disease; hepatitis C virus; muscle wasting; orthotopic liver transplantation; topical testosterone replacement

Indexed keywords

DRONABINOL; TESTOSTERONE; TUMOR MARKER;

ADULT; ANOREXIA; ARTICLE; ASCITES; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GRAFT REJECTION; HEPATIC ENCEPHALOPATHY; HORMONE SUBSTITUTION; HUMAN; LIVER FAILURE; LIVER GRAFT; MALE; MEDICAL RECORD; PARACENTESIS; PRIORITY JOURNAL; PROTEIN DIET; TREATMENT OUTCOME;

EID: 4444346905     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000037810.59358.d2     Document Type: Article

References (12)

1. Amory JK, Anawalt BD, Blaskovich PD, Gilchriest J, Nuwayser ES, Matsumoto AM: Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men. J Androl 23:84-91, 2002
2. Rolf C, Nieschlag E: Potential adverse effects of long-term testosterone therapy. Baillieres Clin Endocrinol Metab 12:521-534, 1998
3. Hengge U: HIV and testosterone therapy [comment]. Lancet Infect Dis 3:187-188, 2003
4. Rabkin JG, Wagner GJ, Rabkin R: A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms [comment]. Arch Gen Psychiatry 57:141-147, 2000 (discussion, 155-146)
5. Dobs AS: Androgen therapy in AIDS wasting. Baillieres Clin Endocrinol Metab 12:379-390, 1998
6. Coodley GO, Coodley MK: An trial of testosterone therapy for HIV-associated weight loss. AIDS 11:1347-1352, 1997
7. Tan RS, Culberson JW: An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas 45:15-27, 2003
8. Allan CA, McLachlan RI: Testosterone deficiency in men. Diagnosis and management. Austral Family Phys 32:422-427, 2003
9. Shahidi NT: A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 23:1355-1390, 2001
10. Brocks DR, Meikle AW, Boike SC, Mazer NA, Zariffa N, Audet PR, Jorkasky DK: Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: Influence of dose. J Clin Pharmacol 36:732-739, 1996
11. Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, Demers LM: Transdermal testosterone therapy in the treatment of male hypogonadism. J Clin Endocrinol Metab 66:546-551, 1988
12. Clague JE, Wu FC, Horan MA: Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men. Int J Androl 22:261-265, 1999